Visible changes in tone and firmness appear at 4 to 8 weeks
For instance, a number of ongoing or completed trials are evaluating inhibitors of the PI3K-AKT-mTOR cascade, such as gedatolisib (NCT03065062) in advanced solid tumors, capivasertib (NCT04305496) in hormone receptor-positive breast cancer, and alpelisib (NCT02437318), which has shown efficacy in advanced breast cancer and is already approved for PIK3CA-mutated cases
Interestingly, the PC group had a nearly normal histological appearance, similar to the sham group, indicating that the post-conditioning treatment had a partial protective effect
50mg vial with 2.5ml bacteriostatic water: 50mg 2.5ml = 20mg/ml For 1mg dose: 1mg 20mg/ml = 0.05ml = 5 units on U-100 syringe 50mg vial with 2ml bacteriostatic water: 50mg 2ml = 25mg/ml For 1mg dose: 1mg 25mg/ml = 0.04ml = 4 units on U-100 syringe 100mg vial with 5ml bacteriostatic water: 100mg 5ml = 20mg/ml For 2mg dose: 2mg 20mg/ml = 0.1ml = 10 units on U-100 syringe Higher concentrations mean smaller injection volumes but require more precise syringe handling
Bring only the doses you need (pre-calculated using a dosage calculator for your tirzepatide dose in units )